The Magazine for Sleep Professionals
Thursday, July 23, 2026
Boehringer Ingelheim Pharmaceuticals, Inc., donated $500,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. […]
Respimat® re-usable has a lower carbon footprint and reduces waste compared with single-use inhalers1,2,3 The device has been designed with patient input and contains features that improve ease of handling and use4 Boehringer Ingelheim announced that its Respimat® re-usable inhaler device is the winner of the 2020 Pharmapack Eco-Design Award. The Pharmapack […]
